We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
(-24%)
Cap. Flow
-$4.42M
Cap. Flow
% of AUM
-7.61%
Top 10 Holdings %
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$2.31M |
| 2 |
Amgen
AMGN
|
+$1.97M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$1.79M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
+$1.56M |
| 5 |
Clorox
CLX
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$5.02M |
| 2 |
Akebia Therapeutics
AKBA
|
+$3.63M |
| 3 |
FL
Foot Locker
FL
|
+$2.12M |
| 4 |
General Mills
GIS
|
+$2.03M |
| 5 |
lululemon athletica
LULU
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.51% |
| 2 | Consumer Staples | 17.11% |
| 3 | Consumer Discretionary | 2.69% |
| 4 | Communication Services | 1.36% |
| 5 | Materials | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYNE
176
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $5K | 0.01% |
+7,000
| New | +$139K |
|
177
PUT
AbbVie
ABBV
$450B
| $4K | 0.01% |
10,000
-72,000
| -88% | -$4.84M |
|
|
178
PUT
Abbott
ABT
$175B
| $4K | 0.01% |
35,000
| – | – |
|
179
CALL
Papa John's
PZZA
$1.08B
| $4K | 0.01% |
15,000
-4,000
| -21% | -$316K |
|
|
TWX
180
PUT
DELISTED
Time Warner Inc
TWX
| $4K | 0.01% |
4,000
-5,000
| -56% | -$495K |
|
181
CALL
Campbell Soup
CPB
$6.58B
| $3K | 0.01% |
17,600
-46,500
| -73% | -$2.63M |
|
182
PUT
Coca-Cola Europacific Partners
CCEP
$46.5B
| $2K | ﹤0.01% |
1,900
+1,500
| +375% | +$59.4K |
|
183
CALL
SCYNEXIS
SCYX
$42.4M
| $2K | ﹤0.01% |
125
-288
| -70% | -$47.7K |
|
184
CALL
TransDigm Group
TDG
$67.9B
| $2K | ﹤0.01% |
+5,000
| New | +$1.27M |
|
|
AKS
185
CALL
DELISTED
AK Steel Holding Corp
AKS
| $2K | ﹤0.01% |
+20,000
| New | +$125K |
|
186
CALL
Agilent Technologies
A
$37.1B
| $1K | ﹤0.01% |
15,500
-34,500
| -69% | -$1.97M |
|
187
PUT
uniQure
QURE
$2.77B
| $1K | ﹤0.01% |
+4,000
| New | +$21.6K |
|
188
CALL
Textron
TXT
$15.9B
| $1K | ﹤0.01% |
+700
| New | +$32.9K |
|
189
CALL
Apple
AAPL
$4.9T
| – | – |
-104,000
| Closed | -$385K |
|
|
190
PUT
Apple
AAPL
$4.9T
| – | – |
-172,000
| Closed | -$35K |
|
191
CALL
Aecom
ACM
$8.78B
| – | – |
-14,300
| Closed | -$3K |
|
192
CALL
Autodesk
ADSK
$46.1B
| – | – |
-17,500
| Closed | -$41K |
|
|
193
PUT
Autodesk
ADSK
$46.1B
| – | – |
-4,000
| Closed | -$2K |
|
194
CALL
Akamai
AKAM
$17.5B
| – | – |
-19,100
| Closed | -$42K |
|
|
195
Akebia Therapeutics
AKBA
$359M
| $0 | ﹤0.01% |
30
-286,447
| -100% | -$3.63M |
|
|
196
PUT
Akebia Therapeutics
AKBA
$359M
| – | – |
-5,000
| Closed | -$5K |
|
|
197
CALL
Amgen
AMGN
$198B
| – | – |
-16,000
| Closed | -$31K |
|
198
CALL
BioCryst Pharmaceuticals
BCRX
$2.36B
| – | – |
-71,700
| Closed | -$179K |
|
199
Bausch Health
BHC
$1.8B
| – | – |
-2,000
| Closed | -$24K |
|
200
CALL
Cal-Maine
CALM
$4.2B
| – | – |
-44,300
| Closed | -$19K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q2 2017 Portfolio in Review
As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, FT Options opened a new position in Amgen worth $2.08M.
- FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
- FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
- FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
- FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
- FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
- FT Options opened 63 new positions and closed 151 in Q2 2017.
- FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.
Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.